Recor Medical and Otsuka Medical Devices Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the Treatment of Hypertension

Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announce the U.S. Food and Drug Administration Circulatory Systems Devices Panel of the Medical Devices Advisory Committee met to discuss the pre-market approval application for the Paradise™ Ultrasound Renal Denervation system, indicated to reduce blood pressure in patients with hypertension.